Status:
COMPLETED
Safety Study of Maraviroc's Effect on Human Osteoclasts
Lead Sponsor:
National Center for Global Health and Medicine, Japan
Conditions:
HIV Infections
AIDS
Eligibility:
All Genders
20+ years
Brief Summary
This study is to investigate the safety of maraviroc by examining whether there is bone metabolism dysfunction in actual use of maraviroc in human body, or not, measuring bone mineral density and mark...
Detailed Description
An observational study to investigate the safety of maraviroc by examining whether there is bone metabolism dysfunction in actual use of maraviroc in human body, or not, measuring bone mineral density...
Eligibility Criteria
Inclusion
- Outpatients or inpatients that are treated for HIV infection at AIDS Clinical Center of National Center for Global Health and Medicine who meet all criteria following:
- Those whose primary care physician acknowledged the necessity of maraviroc treatment due to multi-resistance HIV strain that is confirmed to have CCR5 tropism.
- Those who are willing and able to consent to this study
- 20 years old or older
Exclusion
- Cases applicable to ANY condition of the following:
- Those who are not suited for maraviroc (whose HIV strain to be CXCR4 tropism)
- Others who the principle investigator physician considered to be excluded
Key Trial Info
Start Date :
November 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT01428986
Start Date
November 1 2009
End Date
March 1 2014
Last Update
September 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Center for Global Health and Medicine
Shinjuku, Tokyo, Japan, 1628655